Related Experiment Video

Updated: May 11, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
07:08

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

The apical ES-BTB-BM functional axis is an emerging target for toxicant-induced infertility

Hin-Ting Wan1, Dolores D Mruk, Chris K C Wong

  • 1Center for Biomedical Research, Population Council, 1230 York Ave, New York, NY 10065, USA.

Trends in Molecular Medicine
|May 7, 2013
PubMed

Insights

Toxicants disrupt the apical ectoplasmic specialization-blood-testis barrier-basement membrane axis in testes, impairing sperm production. Small molecules may offer a way to interfere with this toxicant-induced disruption.

Area of Science:

  • Reproductive toxicology
  • Spermatogenesis
  • Cellular biology

Background:

  • The testes contain a critical functional axis: the apical ectoplasmic specialization (apical ES)-blood-testis barrier (BTB)-basement membrane (BM).
  • This axis is highly sensitive to environmental toxicants like cadmium and phthalates.

Purpose of the Study:

  • To elucidate the mechanisms by which toxicants disrupt spermatogenesis.
  • To investigate the role of the apical ES-BTB-BM axis in toxicant-induced testicular damage.

Main Methods:

  • The study likely involved exposure of testicular tissues or cells to specific toxicants.
  • Analysis of cellular signaling and structural integrity of the apical ES-BTB-BM axis.
  • Investigation of drug transporter function and localization.

Main Results:

  • Toxicants activate Sertoli cells upon contacting the basement membrane, perturbing signaling within the apical ES-BTB-BM axis.
  • Toxicants can disrupt spermatogenesis without direct entry into the epithelium.
  • Downregulation of efflux transporters by toxicants traps them within the epithelium, exacerbating damage.

Conclusions:

  • A novel model of toxicant-induced disruption of spermatogenesis is proposed, centered on the apical ES-BTB-BM axis.
  • This pathway presents a potential target for therapeutic intervention using small molecules.

More Related Videos

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays08:28

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...